| |
| |
|
| Insider
Information: |
Lederman Seth |
| Relationship: |
Chief Executive Office... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,505 |
|
|
Indirect Shares
|
24,249 |
|
|
| Direct
Value |
$615 |
|
|
|
Indirect Value
|
$4,256 |
|
|
| Total
Shares |
27,754 |
|
|
| Total
Value |
$4,871 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tonix Pharmaceuticals Holding Corp |
TNXP |
Chief Executive Office... |
2022-06-29 |
3,505 |
2022-06-29 |
24,249 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
45 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2014-03-18 |
4 |
A |
$12.15 |
$607,500 |
I/I |
50,000 |
29,167 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-12-31 |
5 |
A |
$6.46 |
$11,247 |
D/D |
1,741 |
72,815 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-30 |
5 |
A |
$1.74 |
$5,735 |
D/D |
3,296 |
79,111 |
0 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • • |
2013-05-20 |
4 |
B |
$7.00 |
$7,300 |
D/D |
1,000 |
38,309 |
3.15 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
President and CEO |
• • – |
2013-08-14 |
4 |
B |
$0.00 |
$0 |
D/D |
11,765 |
50,074 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-02-09 |
4 |
B |
$5.85 |
$29,250 |
D/D |
5,000 |
55,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-04 |
4 |
B |
$6.05 |
$6,050 |
D/D |
1,000 |
56,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-05 |
4 |
B |
$6.48 |
$6,480 |
D/D |
1,000 |
57,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-06 |
4 |
B |
$6.45 |
$6,450 |
D/D |
1,000 |
58,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-09 |
4 |
B |
$6.50 |
$6,500 |
D/D |
1,000 |
59,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-10 |
4 |
B |
$6.90 |
$6,900 |
D/D |
1,000 |
60,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-11 |
4 |
B |
$7.00 |
$7,000 |
D/D |
1,000 |
61,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-12 |
4 |
B |
$7.26 |
$7,260 |
D/D |
1,000 |
62,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-13 |
4 |
B |
$7.21 |
$7,210 |
D/D |
1,000 |
63,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-16 |
4 |
B |
$6.85 |
$6,853 |
D/D |
1,000 |
64,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-03-17 |
4 |
B |
$7.18 |
$7,180 |
D/D |
1,000 |
65,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-07-17 |
4 |
B |
$7.50 |
$45,000 |
I/I |
6,000 |
6,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2015-09-25 |
4 |
B |
$6.50 |
$39,000 |
D/D |
6,000 |
71,074 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-03-23 |
4 |
B |
$2.44 |
$19,537 |
D/D |
8,000 |
80,815 |
2.81 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-21 |
4 |
B |
$2.00 |
$50,000 |
I/I |
25,000 |
31,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-06-22 |
4 |
B |
$2.08 |
$41,500 |
I/I |
20,000 |
20,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
10,000 |
90,815 |
2.73 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2016-11-21 |
4 |
B |
$0.43 |
$41,924 |
I/I |
98,000 |
133,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-06-20 |
4 |
B |
$4.22 |
$84,400 |
I/I |
20,000 |
20,000 |
2.66 |
- |
|
| TNXP |
Tonix Pharmaceuticals Hol... |
Chief Executive Officer |
• • – |
2017-06-26 |
4 |
B |
$4.40 |
$22,000 |
I/I |
5,000 |
25,000 |
2.58 |
- |
|
45 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
